Pre-eclampsia: Challenges for Nanomedicine Development in Pregnancy

Pre-eclampsia is responsible for ~70 000 maternal and 500 000 fetal deaths annually. The placenta releases excess anti-angiogenic factors into the maternal circulation, causing systemic vascular and organ injury, hypertension, and fetal growth restriction. Current management strategies focus on preparation for delivery. There are no treatments that halt disease progression.